{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_001048200.2:c.158C>T",
          "cDNA Change": {
            "transcript": "NM_001048200.2",
            "ref": "C",
            "alt": "T",
            "position": "158"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "V",
            "position": "53"
          },
          "Description in input context": "A53T (c.158C>T)"
        },
        {
          "HGVS": "NM_001048200.2:c.658G>A",
          "cDNA Change": {
            "transcript": "NM_001048200.2",
            "ref": "G",
            "alt": "A",
            "position": "658"
          },
          "Protein Change": {
            "ref": "E",
            "alt": "K",
            "position": "220"
          },
          "Description in input context": "E220K (c.658G>A)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0010958"
  },
  "Experiment Method": [
    {
      "Assay Method": "Western Blot",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293",
        "Description": "The experiment was conducted using HEK293 cells expressing wild-type and mutant SNCA."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001048200.2:c.158C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "A53T variant showed increased alpha-synuclein aggregation and reduced protein solubility."
        },
        {
          "Variant": "NM_001048200.2:c.658G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "E220K variant exhibited enhanced aggregation propensity compared to wild-type."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three independent biological replicates were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was analyzed in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type SNCA-expressing cells served as positive controls."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector-transfected cells were used as negative controls."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "1"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA with post-hoc Tukey's test was used."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Protein solubility > 80% and aggregation < 20%.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Protein solubility < 50% and aggregation > 50%.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Thioflavin T (ThT) Assay",
      "Material used": {
        "Material Source": "Recombinant protein",
        "Material Name": "Recombinant alpha-synuclein",
        "Description": "Aggregation kinetics were measured using recombinant wild-type and mutant alpha-synuclein."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001048200.2:c.158C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "A53T variant showed significantly faster aggregation kinetics (t1/2 = 2.5 hours vs. 6.0 hours for wild-type)."
        },
        {
          "Variant": "NM_001048200.2:c.658G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "E220K variant exhibited increased ThT fluorescence intensity (3.2-fold vs. 1.0 for wild-type)."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "No",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each experiment was repeated in quadruplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "AÎ²40 peptide was used as a positive control for amyloid aggregation."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Bovine serum albumin (BSA) was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "No",
        "Description": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Description": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Two-way ANOVA with Bonferroni correction."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "ThT fluorescence < 1.5-fold of wild-type.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "ThT fluorescence > 2.5-fold of wild-type.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}